back to Newsletters
This month kicks off another great year of the Biodesign Fellowship!
In this August issue:
Upcoming Alumni Association Events
General Announcements
Welcome New Fellows!
Biodesign Alumni Consulting Group
Global Biodesign Alumni
Volunteer to Shape the Next Class of Fellows!
New Biodesign Alumni Blog Posts
Policy Changes that Affect You
New Additions
Upcoming Alumni Association Events
NEW FELLOWS WELCOME HAPPY HOUR | END-AUGUST
TBD - Stay tuned for more details!
Keep an eye on your inbox for event details on a hosted happy hour to meet the new 2013-2014 class of Biodesign Fellows!
BIODESIGN CANDIDATE INTERVIEW EVENTS | WEDNESDAY & THURSDAY, OCTOBER 16 & 17
Save the dates! Join Biodesign in welcoming the interviewees with a cocktail hour on Wednesday and the interview reception on Thursday. After the grueling interview process, these candidates will surely need some drinking buddies!
TABLESIDE CHAT WITH TARSUS MEDICAL | WEDNESDAY, OCTOBER 23
Save the Date!
Our next tableside chat will feature Biodesign alums Nick Mourlas ('01-'02 Fellow), CEO, and Avi Roop ('08-'09 Fellow), Director of Sales & Marketing for Tarsus Medical, which was acquired by Integra LifeSciences earlier this year.
General Announcements
WELCOME NEW FELLOWS!
Please welcome an impressive crop of new Biodesign Fellows, who started the 2013-2014 fellowship year on August 1st! The new fellows are: Varun Boriah MS, Tiffany Chao MD,Nicholas Damiano MS, Ryan Krone PhD, Shreya Mehta MS, Kathryn Olson MS, Holly Rockweiler MS, Jonathan Steinberger MD, and John Woock PhD. The areas of focus for this year's teams will be Urology and Nephrology.
BIODESIGN CONSULTING GROUP
Biodesign is researching the possibility of creating an alumni consulting group. The objectives of this group would be to provide program sponsors and other corporations with direct, hands-on support in implementing the Biodesign process within their organization, create an opportunity for newly graduating fellows and alumni to work with innovation teams within large corporations and develop a platform to consistently deliver the best practices of the Biodesign process to a wide range of corporate clients. We would like to gauge the interest of the alumni group in participating in such an endeavor. Please take a few moments to complete a short 5 question survey. Your input would be greatly appreciated! Take survey!
GLOBAL BIODESIGN ALUMNI GROUP
As the Stanford India Biodesign and Stanford Singapore Biodesign alumni expand in numbers, there has been increased interest in forming a Global Biodesign Alumni (GBA) group. The GBA would provide a local alumni resource for the Global Alumni and interface with the Bay Area alumni to maintain the overall Biodesign Alumni Network. We would like to gather your input to help create a group that best serves your needs. Please help us by completing this survey. Take survey!
HELP WITH BIODESIGN APPLICATION SCREENING
The Biodesign Faculty are looking for alumni to help with applicant screening in the upcoming application cycle. We are just short a couple of volunteers! This is a rewarding way to give back to Biodesign and provides interesting insight into the selection process. Please contact Beverly Tang (btangy@stanford.edu) if you are interested in participating.
New Biodesign Blog Posts
THE RISE OF CV INGENUITY: BREAKING ALL THE "RULES"
by Michael Schaller
posted July 29, 2013
"Trade-offs drive success, conviction drives success, and team drives success."
Duke Rohlen closed our Biodesign Alumni Annual Event with this quip and it provides a great summary of the CV Ingenuity (CVI) story. As CEO and president, Duke was joined by CFO Doug Koo and NEA investor Justin Klein for a panel discussion that highlighted the company's path.
Read More
Policy Changes that Affect You
REPEALING DEVICE TAX CLOSER THAN EVER
But will it happen? GOP freshmen push House to move on bill while Senate symbolically supported it 79-20 in a budget resolution a few months back. Most agree that taxing young, innovative, non-profitable companies stifles innovation, but no one in Congress can agree how to make up the lost revenues. So far, medical device companies have paid $1 billion for the excise tax, which the MDMA argues could have been used for new R&D, capital investments, and supporting jobs. Read More.
CONGRESS MOVES TO PROTECT FDA USER FEES FROM SEQUESTRATION
Back in March, FDA got $210 million carved out of its $4.1 billion 2013 budget, including the user fees. Read more.
New Additions
Please welcome baby girl Allie, born to Brian Fahey ('07-'08 Fellow) on July 15, 2013!
August 2013
- Upcoming Alumni Association Events
- General Announcements
- Welcome New Fellows!
- Biodesign Alumni Consulting Group
- Global Biodesign Alumni
- Volunteer to Shape the Next Class of Fellows!
- New Biodesign Alumni Blog Posts
- Policy Changes that Affect You
- New Additions
Upcoming Alumni Association Events
BIODESIGN CANDIDATE INTERVIEW EVENTS | WEDNESDAY & THURSDAY, OCTOBER 16 & 17
Save the dates! Join Biodesign in welcoming the interviewees with a cocktail hour on Wednesday and the interview reception on Thursday. After the grueling interview process, these candidates will surely need some drinking buddies!
TABLESIDE CHAT WITH TARSUS MEDICAL | WEDNESDAY, OCTOBER 23
Our next tableside chat will feature Biodesign alums Nick Mourlas (’01-’02 Fellow), CEO, and Avi Roop (’08-’09 Fellow), Director of Sales & Marketing for Tarsus Medical, which was acquired by Integra LifeSciences earlier this year.
General Announcements
WELCOME NEW FELLOWS!
Please welcome an impressive crop of new Biodesign Fellows, who started the 2013-2014 fellowship year on August 1st! The new fellows are: Varun Boriah MS, Tiffany Chao MD,Nicholas Damiano MS, Ryan Krone PhD, Shreya Mehta MS, Kathryn Olson MS, Holly Rockweiler MS, Jonathan Steinberger MD, and John Woock PhD. The areas of focus for this year’s teams will be Urology and Nephrology.
BIODESIGN CONSULTING GROUP
Biodesign is researching the possibility of creating an alumni consulting group. The objectives of this group would be to provide program sponsors and other corporations with direct, hands-on support in implementing the Biodesign process within their organization, create an opportunity for newly graduating fellows and alumni to work with innovation teams within large corporations and develop a platform to consistently deliver the best practices of the Biodesign process to a wide range of corporate clients. We would like to gauge the interest of the alumni group in participating in such an endeavor. Please take a few moments to complete a short 5 question survey. Your input would be greatly appreciated! Take survey!
GLOBAL BIODESIGN ALUMNI GROUP
As the Stanford India Biodesign and Stanford Singapore Biodesign alumni expand in numbers, there has been increased interest in forming a Global Biodesign Alumni (GBA) group. The GBA would provide a local alumni resource for the Global Alumni and interface with the Bay Area alumni to maintain the overall Biodesign Alumni Network. We would like to gather your input to help create a group that best serves your needs. Please help us by completing this survey. Take survey!
HELP WITH BIODESIGN APPLICATION SCREENING
The Biodesign Faculty are looking for alumni to help with applicant screening in the upcoming application cycle. We are just short a couple of volunteers! This is a rewarding way to give back to Biodesign and provides interesting insight into the selection process. Please contact Beverly Tang (btangy@stanford.edu) if you are interested in participating.
New Biodesign Blog Posts
THE RISE OF CV INGENUITY: BREAKING ALL THE “RULES”
by Michael Schaller
posted July 29, 2013
“Trade-offs drive success, conviction drives success, and team drives success.”
Duke Rohlen closed our Biodesign Alumni Annual Event with this quip and it provides a great summary of the CV Ingenuity (CVI) story. As CEO and president, Duke was joined by CFO Doug Koo and NEA investor Justin Klein for a panel discussion that highlighted the company’s path.
Read More
REPEALING DEVICE TAX CLOSER THAN EVER
But will it happen? GOP freshmen push House to move on bill while Senate symbolically supported it 79-20 in a budget resolution a few months back. Most agree that taxing young, innovative, non-profitable companies stifles innovation, but no one in Congress can agree how to make up the lost revenues. So far, medical device companies have paid $1 billion for the excise tax, which the MDMA argues could have been used for new R&D, capital investments, and supporting jobs. Read More.
Back in March, FDA got $210 million carved out of its $4.1 billion 2013 budget, including the user fees. Read more.
New Additions
Please welcome baby girl Allie, born to Brian Fahey (’07-’08 Fellow) on July 15, 2013!
Biodesign Alumni 